These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12824953)

  • 1. Long-term efficacy of steady-dose metformin in type 2 diabetes mellitus: a retrospective study.
    Drzewoski J; Czupryniak L
    Med Sci Monit; 2003 Jun; 9(6):CR240-3. PubMed ID: 12824953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus.
    Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A
    J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glimepiride versus pioglitazone combination therapy in subjects with type 2 diabetes inadequately controlled on metformin monotherapy: results of a randomized clinical trial.
    Umpierrez G; Issa M; Vlajnic A
    Curr Med Res Opin; 2006 Apr; 22(4):751-9. PubMed ID: 16684436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of acarbose in diabetes mellitus: a critical review of controlled trials.
    Scheen AJ
    Diabetes Metab; 1998 Sep; 24(4):311-20. PubMed ID: 9805641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gliclazide and metformin combination in patients with type 2 diabetes. Preliminary data].
    Galeone F; Fiore G; Arcangeli A; Mannucci E
    Minerva Endocrinol; 1998 Sep; 23(3):71-5. PubMed ID: 10063324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.
    Hausmann M; Dellweg S; Osborn C; Heinemann L; Buchwald A; Rosskamp R; Genova P; Heise T
    Diabetes Obes Metab; 2006 Sep; 8(5):574-80. PubMed ID: 16918593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate insulin initiation dosage for insulin-naive type 2 diabetes outpatients receiving insulin monotherapy or in combination with metformin and/or pioglitazone.
    Liao L; Yang M; Qiu LL; Mou YR; Zhao JJ; Dong JJ
    Chin Med J (Engl); 2010 Dec; 123(24):3684-8. PubMed ID: 22166651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfonylurea-metformin-combination versus sulfonylurea-insulin-combination in secondary failures of sulfonylurea monotherapy. Results of a prospective randomized study in 50 patients.
    Klein W
    Diabete Metab; 1991 May; 17(1 Pt 2):235-40. PubMed ID: 1936483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of acarbose efficacy and safety for treatment of diabetes mellitus. Testing of observations under general health care conditions].
    Sieradzki J; Soszyński P
    Przegl Lek; 1999; 56(5):335-41. PubMed ID: 10554569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients.
    Balasubramanian R; Varadharajan S; Kathale A; Nagraj LM; Periyandavar I; Nayak UP; Sharma A; Bolmall C; Baliga VP
    J Indian Med Assoc; 2008 Jul; 106(7):464-7. PubMed ID: 18975505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medication use in diabetes mellitus (VI). Economics and effectiveness of insulin and sulfonyl-urea combination therapy compared with conventional two daily doses].
    Costa B; Estopá A; Borrás J; Sabaté A
    Med Clin (Barc); 1998 Nov; 111(15):568-72. PubMed ID: 9859089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-glucose self-monitoring in insulin treated type 2 diabetes mellitus a cross-sectional study with an intervention group.
    Schiel R; Müller UA; Rauchfub J; Sprott H; Müller R
    Diabetes Metab; 1999 Sep; 25(4):334-40. PubMed ID: 10566123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2 diabetes in the elderly: an assessment of metformin (metformin in the elderly).
    Lalau JD; Vermersch A; Hary L; Andrejak M; Isnard F; Quichaud J
    Int J Clin Pharmacol Ther Toxicol; 1990 Aug; 28(8):329-32. PubMed ID: 2272714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ten-year follow-up of antidiabetic drug use, nonadherence, and mortality in a defined population with type 2 diabetes mellitus.
    Brown JB; Nichols GA; Glauber HS; Bakst A
    Clin Ther; 1999 Jun; 21(6):1045-57. PubMed ID: 10440626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Initiating insulin therapy in patients with diabetes mellitus type 2: in a transmural setting is at least as effective as in an outpatient setting; a retrospective study with a 4-year follow-up].
    Rosendal H; Vondeling H; de Witte LP; Hutubessy RC; van Beekum WT; Heine RJ
    Ned Tijdschr Geneeskd; 2002 Jan; 146(4):166-71. PubMed ID: 11845567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aspects of antihyperglycemic oral bitherapy in 76 cases of non insulindependent diabetes in Dakar].
    Sidibé EH; Badiane MK; Gueye A
    Sante; 2002; 12(3):319-22. PubMed ID: 12473527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring the role of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus.
    Graham JP; Stam D
    Pharm Pract Manag Q; 1997 Oct; 17(3):1-9. PubMed ID: 10173306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.